The 27 references in paper Т. Мартынюк В., З. Дадачева Х., И. Чазова Е., Т. Мартынюк В., З. Дадачева Х., И. Чазова Е. (2015) “ВОЗМОЖНОСТИ МЕДИКАМЕНТОЗНОГО ЛЕЧЕНИЯ ХРОНИЧЕСКОЙ ТРОМБОЭМБОЛИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИИ” / spz:neicon:aterotromboz:y:2015:i:1:p:87-98

1
Kim NH, Delcroix M, Jenkins DP et al. Chronic Thromboembolic Pulmonary Hypertension. J Am Coll Cardiol, 2013, 62(Suppl): 92–99.
(check this in PDF content)
2
Чазова И.Е., Авдеев С.Н., Царева Н.А., соавт. Клинические рекомендации по диагностике и лечению легочной гипертензии. Терапевтический архив, 2014, 9: 4—23.
(check this in PDF content)
3
GaliП N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J,2009, 30: 2493–2537.
(check this in PDF content)
4
Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation, 2006, 113: 2011–2020.
(check this in PDF content)
5
Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med, 2001, 345: 1465–72.
(check this in PDF content)
6
Pengo V, Lensing AW, Prins MH, et al.Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med, 2004, 350: 2257–64.
(check this in PDF content)
7
Tapson VF, Humbert M. Incidence and Prevalens of Chronic Thromboembolic Pulmonary Hypertension. Proc Am Thorac Soc,2006, 3: 564–567.
(check this in PDF content)
8
Pepke-Zaba J, Delcroix M, Lang I et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation, 2011, 124: 1973–1981.
(check this in PDF content)
9
Riedel M, Stanek V, Widimsky J et. al. Long-term follow-up of patients with pulmonary thromboembolism: late prognosis and evolusion of hemodynamic and respiratori data. Chest, 1982, 81: 151–8.
(check this in PDF content)
10
Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force fo the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J,2008, 28: 2276–2315.
(check this in PDF content)
11
Wilkens H, Lang I, Behr J, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations of the Cologne Consensus Conference 2011. Int J Cardiol, 2011, 154: S54–60.
(check this in PDF content)
12
Мершин К.В., Акчурин Р.С. Глава «Хроническая тромбоэмболическая легочная гипертензия». Легочная гипертензия. Под ред. Чазова И.Е., Мартынюк. М.: Практика 2015. С. 563–602.
(check this in PDF content)
13
Reichenberger F., Voswinckel R., Enke B. et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J,2007, 30: 922–927.
(check this in PDF content)
14
Reesink HJ, Surie S, Kloek JJ et al. Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg, 2009, 139: 85–91.
(check this in PDF content)
15
Cabrol S, Souza R, Jais X et al. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant, 2007, 26: 357–62.
(check this in PDF content)
16
Skoro-Sajer N, Bonderman D, Wiesbauer F, Harja E, Jakowitsch J, Klepetko W, Kneussl MP, Lang IM. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2007; 5: 483–489.
(check this in PDF content)
17
Bresser P, Fedullo PF, Auger WR et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J,2004, 23: 595–600.
(check this in PDF content)
18
Nagaya N, Sasaki N, Ando M et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest,2003, 123: 338–343.
(check this in PDF content)
19
Suntharalingam J, Treacy CM, Doughty NJ, et al. Longterm use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest, 2008, 134: 229–236.
(check this in PDF content)
20
Дадачева З.Х., Мартынюк Т.В., Саидова М.А. с соавт. Клинический случай успешного применения силденафила в высоких дозах в лечении пациентки с неоперабельной хронической тромбоэмболической легочной гипертензией. Евразийский кардиологический журнал, 2014, 4: 34–44.
(check this in PDF content)
21
Condliffe R, Kiely DG, Gibbs JS et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension patients. Am J Respir Crit Care Med,2008, 177: 1122–1127.
(check this in PDF content)
22
Bonderman D, Nowotny R, Skoro-Sajer N et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest,2005, 128: 2599–2603.
(check this in PDF content)
23
Jais X, D’Armini AM, Jansa P et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in inoperable forms of chronic thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol2008, 52: 2127–2134.
(check this in PDF content)
24
Ghofrani H-A, D’armini AM, Grimminger F et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med, 2013, 369: 319–329 (+Supplementary Appendix; +Protocol).
(check this in PDF content)
25
Simonneau G, D’Armini AM, Ghofrani H-A, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J,2014, in press| DOI: 10.1183/09031936.00087114.
(check this in PDF content)
26
Konstantinides S, Torbicki A, et al. ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J,2014, 35: 3033–80.
(check this in PDF content)
27
European medicines agency. Committee for Medicinal Products for Human Use (CHMP) assessment report. EMA/CHMP/734750/2013. 23 January 2014. Adempas. Procedure No. EMEA/H/C/002737/0000.
(check this in PDF content)